Clinical trial results

Explore the landscape of Clinical trial results in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial results to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Asymchem's Tianjin Macromolecule Site Passes First FDA Pre‑Approval Inspection – EIR Issued for Commercial API Facility
Company

Asymchem’s Tianjin Macromolecule Site Passes First FDA Pre‑Approval Inspection – EIR Issued for Commercial API Facility

Asymchem Laboratories (Tianjin) Co., Ltd. (SHE: 002821; HKG: 6821) announced that its Chemistry Macromolecule Base, located in the West District of the Tianjin Economic‑Technological Development Area (TEDA), completed a US…

Pfizer's Oral Ritlecitinib Meets Primary Endpoints in Phase III Nonsegmental Vitiligo Trials – Largest‑Ever Oral Systemic Program Clears Path for Global Filings

Pfizer’s Oral Ritlecitinib Meets Primary Endpoints in Phase III Nonsegmental Vitiligo Trials – Largest‑Ever Oral Systemic Program Clears Path for Global Filings

Qyuns Therapeutics' Oturkibart Delivers Late‑Breaking Phase III Data in Prurigo Nodularis at EADV 2026 – IL‑4Rα Antibody Beats Placebo on Itch and Lesion Clearance

Qyuns Therapeutics’ Oturkibart Delivers Late‑Breaking Phase III Data in Prurigo Nodularis at EADV 2026 – IL‑4Rα Antibody Beats Placebo on Itch and Lesion Clearance

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Novo Nordisk's Semaglutide Meets Primary Endpoints in ESSENCE Phase III Study for MASH
CompanyDrug

Novo Nordisk’s Semaglutide Meets Primary Endpoints in ESSENCE Phase III Study for MASH

Jenscare Scientific's LuX-Valve Plus Shows Positive One-Year Results in TRAVEL II Study
CompanyMedical Device

Jenscare Scientific’s LuX-Valve Plus Shows Positive One-Year Results in TRAVEL II Study

Sino Medical Reports Five-Year PIONEER Study Results for HT Supreme Stent System
CompanyMedical Device

Sino Medical Reports Five-Year PIONEER Study Results for HT Supreme Stent System

Zai Lab Reports Positive Phase III Results for KarXT, Showcasing Efficacy in Psychiatric Conditions
CompanyDrug

Zai Lab Reports Positive Phase III Results for KarXT, Showcasing Efficacy in Psychiatric Conditions

Innovent Biologics' Picankibart Shows 64.6% Skin Clearance in Phase II Psoriasis Study
CompanyDrug

Innovent Biologics’ Picankibart Shows 64.6% Skin Clearance in Phase II Psoriasis Study

Clover Biopharmaceuticals Reports Strong Phase I Results for RSV Vaccine SCB-1019
CompanyDrug

Clover Biopharmaceuticals Reports Strong Phase I Results for RSV Vaccine SCB-1019

Eli Lilly’s Ebglyss Shows Positive Results in Phase III Study for Atopic Dermatitis Patients Previously Treated with Dupilumab
CompanyDrug

Eli Lilly’s Ebglyss Shows Positive Results in Phase III Study for Atopic Dermatitis Patients Previously Treated with Dupilumab

Biogen's Felzartamab Demonstrates Promising Results in Phase II Study for IgA Nephropathy
CompanyDrug

Biogen’s Felzartamab Demonstrates Promising Results in Phase II Study for IgA Nephropathy

Show More